Profile: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,830JPY
30 Jan 2015
Change (% chg)

¥6 (+0.36%)
Prev Close
¥1,823
Open
¥1,840
Day's High
¥1,862
Day's Low
¥1,828
Volume
8,889,700
Avg. Vol
7,996,438
52-wk High
¥1,862
52-wk Low
¥1,062

Search Stocks
Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, atopic dermatitis and other diseases. As of March 31, 2014, the Company had 79 subsidiaries and six associated companies.

Company Address

Astellas Pharma Inc

2-5-1, Nihombashihon-cho
CHUO-KU   TKY   103-8411
P: +813.32443000

Company Web Links

Search Stocks